Advertisement
Videos
Advertisement

Low “T” Drugs Raise Medical Questions

Tue, 05/28/2013 - 8:55am

In the past year, pharmaceutical companies have spent more than $100 million marketing low-testosterone, or low-t, drug treatments, but Consumer Reports’ medical experts says the benefits might not outweigh the many risks associated with these products.

Visit NBCNews.com for breaking news, world news, and news about the economy

Advertisement

Share this Story

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading